Evidence map›Paper›PMID 29708591›Full record

ArticleInternational journal of cancer2018

Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancer.

Michelle L Baglia, Linda S Cook, C Mei-Tzu, Charles Wiggins, Deirdre Hill, Peggy Porter, Christopher I Li

Abstract read
In one paragraph

Article in International journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  4. Article
  5. Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients.International journal of environmental research and public health · 2022
    Article
  6. Prognostic Prediction of BRCA Mutations byMolecular imaging and radionuclide therapy · 2021
    Article
  7. Article
  8. Article
  9. Alcohol's Effects on Breast Cancer in Women.Alcohol research : current reviews · 2020
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michelle L BagliaDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0001-8990-4572
Linda S CookDepartment of Internal Medicine, University of New Mexico (UNM) and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico.
C Mei-TzuDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
Charles WigginsDepartment of Internal Medicine, University of New Mexico (UNM) and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico.
Deirdre HillDepartment of Internal Medicine, University of New Mexico (UNM) and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico.
Peggy PorterDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
Christopher I LiDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.

Funding

Understanding and preventing breast cancer disparties in LatinasP50CA148143 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMPSON, BETI · 2010 to 2016
$9.7M
National Cancer Institute (NCI) 261201000029CNational Cancer Institute (NCI) 261201000033CNational Cancer Institute (NCI) P50 CA148143NCI NIH HHS HHSN261201000029CNCI NIH HHS HHSN261201000033CNCI NIH HHS P50 CA148143
6 · The paper itself

Abstract

Epidemiological evidence is limited on how alcohol consumption and smoking are associated with risk of different subtypes of breast cancer, such as triple-negative (TN) and human epidermal growth factor receptor 2-overexpressing (H2E) breast cancers, which may have different etiologies from more common luminal (estrogen receptor [ER+]) breast cancers. In this population-based case-case study, we evaluated the association between alcohol, smoking, and risk of H2E and TN breast cancer, compared with ER+ breast cancers, among women aged 20-69 years. Using polytomous regression, associations between alcohol consumption, smoking, and breast cancer risk were evaluated in 909 ER+, 1,290 TN, and 489 H2E breast cancer patients, with ER+ breast cancer patients as the reference group. Current alcohol consumption at diagnosis was associated with a lower risk of H2E breast cancer (odds ratio = 0.74, 95% confidence interval: 0.58-0.92) relative to ER+ cancers. No difference in association was observed by menopausal status. No association between alcohol consumption and TN breast cancer relative to ER+ breast cancer was observed. Women who smoked did not have an altered risk of TN or H2E breast cancer, relative to ER+ cancer. Our results suggest that alcohol is associated with lower risk of H2E breast cancer relative to ER+ breast cancer. This study adds to the body of epidemiologic evidence that breast cancer etiology differs by breast cancer subtype.

Indexed as

AdultAgedAlcohol DrinkingErb-b2 Receptor Tyrosine KinasesEthanolFemaleHumansMiddle AgedOdds RatioReceptors, EstrogenReceptors, ProgesteroneRiskSmokingTobacco SmokingTriple Negative Breast NeoplasmsYoung AdultERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesEthanolReceptors, EstrogenReceptors, Progesteronealcoholbreast cancerHer2-overexpressingsmokingtriple-negative

Identifiers

PMID29708591
PMCPMC6158121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.